Comments

Axsome Therapeutics

AXSMNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$86.05
1.21.41%
At Close: -
$86.88
0.830.96%
After Hours: 5:44 PM EDT
15 minutes delayed
Q2 2024 Earnings in 14 days from now on Mon Aug 5th, before the market open
Axsome Therapeutics (AXSM) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesGovernment TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$190.00
Lowest Price Target1
$49.00
Consensus Price Target1
$113.53

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Axsome Therapeutics (NASDAQ:AXSM) Stock, Analyst Ratings, Price Targets, Forecasts

Axsome Therapeutics Inc has a consensus price target of $113.53 based on the ratings of 19 analysts. The high is $190 issued by HC Wainwright & Co. on June 6, 2024. The low is $49 issued by Mizuho on May 3, 2022. The 3 most-recent analyst ratings were released by RBC Capital, Needham, and B of A Securities on July 22, 2024, July 22, 2024, and July 18, 2024, respectively. With an average price target of $118.67 between RBC Capital, Needham, and B of A Securities, there's an implied 36.59% upside for Axsome Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Mar
2
Apr
1
May
1
Jun
1
1
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Needham
B of A Securities
Mizuho
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Axsome Therapeutics

Buy NowGet Alert
07/22/2024Buy Now50.79%RBC Capital
Leonid Timashev
$131 → $131ReiteratesOutperform → OutperformGet Alert
07/22/2024Buy Now49.64%Needham
Ami Fadia
 → $130Initiates → BuyGet Alert
07/18/2024Buy Now9.35%B of A Securities
Jason Gerberry
$97 → $95MaintainsNeutralGet Alert
06/12/2024Buy Now22.01%Mizuho
Graig Suvannavejh
—ReiteratesBuy → BuyGet Alert
06/06/2024Buy Now118.71%HC Wainwright & Co.
Raghuram Selvaraju
$190 → $190ReiteratesBuy → BuyGet Alert
06/05/2024Buy Now49.64%RBC Capital
Leonid Timashev
$127 → $130MaintainsOutperformGet Alert
05/08/2024Buy Now22.01%Mizuho
Graig Suvannavejh
$109 → $106MaintainsBuyGet Alert
05/07/2024Buy Now118.71%HC Wainwright & Co.
Raghuram Selvaraju
 → $190ReiteratesBuy → BuyGet Alert
05/07/2024Buy Now43.88%Citigroup
David Hoang
$127 → $125MaintainsBuyGet Alert
05/07/2024Buy Now28.92%Baird
Joel Beatty
$108 → $112MaintainsOutperformGet Alert
04/29/2024Buy Now32.37%Morgan Stanley
Vikram Purohit
$90 → $115UpgradeEqual-Weight → OverweightGet Alert
04/10/2024Buy Now23.17%Cantor Fitzgerald
Charles Duncan
 → $107ReiteratesOverweight → OverweightGet Alert
04/02/2024Buy Now118.71%HC Wainwright & Co.
Raghuram Selvaraju
$190 → $190MaintainsBuyGet Alert
03/28/2024Buy Now25.47%Mizuho
Graig Suvannavejh
$108 → $109MaintainsBuyGet Alert
03/26/2024Buy Now72.66%Truist Securities
Joon Lee
 → $150MaintainsBuyGet Alert
03/26/2024Buy Now47.34%RBC Capital
Leonid Timashev
$123 → $128MaintainsOutperformGet Alert
03/26/2024Buy Now46.19%Citigroup
David Hoang
$125 → $127MaintainsBuyGet Alert
03/26/2024Buy Now118.71%HC Wainwright & Co.
Raghuram Selvaraju
$180 → $190MaintainsBuyGet Alert
03/20/2024Buy Now107.19%HC Wainwright & Co.
Raghuram Selvaraju
 → $180ReiteratesBuy → BuyGet Alert
03/19/2024Buy Now24.32%Baird
Joel Beatty
 → $108Initiates → OutperformGet Alert
03/04/2024Buy Now107.19%HC Wainwright & Co.
Raghuram Selvaraju
 → $180ReiteratesBuy → BuyGet Alert
02/27/2024Buy Now24.32%Mizuho
Graig Suvannavejh
$112 → $108MaintainsBuyGet Alert
02/21/2024Buy Now43.88%Guggenheim
Yatin Suneja
$110 → $125MaintainsBuyGet Alert
02/21/2024Buy Now41.58%RBC Capital
Leonid Timashev
$126 → $123MaintainsOutperformGet Alert
02/21/2024Buy Now18.56%Cantor Fitzgerald
Charles Duncan
$108 → $103MaintainsOverweightGet Alert
02/20/2024Buy Now24.32%Cantor Fitzgerald
Charles Duncan
 → $108ReiteratesOverweight → OverweightGet Alert
02/16/2024Buy Now28.92%Mizuho
Graig Suvannavejh
$90 → $112MaintainsBuyGet Alert
02/06/2024Buy Now27.77%UBS
Ashwani Verma
 → $111Initiates → BuyGet Alert
01/25/2024Buy Now45.04%RBC Capital
Leonid Timashev
 → $126Initiates → OutperformGet Alert
01/22/2024Buy Now24.32%Cantor Fitzgerald
Charles Duncan
 → $108ReiteratesOverweight → OverweightGet Alert
01/16/2024Buy Now30.07%Piper Sandler
David Amsellem
$90 → $113MaintainsOverweightGet Alert
12/26/2023Buy Now107.19%HC Wainwright & Co.
Raghuram Selvaraju
 → $180ReiteratesBuy → BuyGet Alert
12/20/2023Buy Now24.32%Cantor Fitzgerald
Charles Duncan
 → $108ReiteratesOverweight → OverweightGet Alert
12/13/2023Buy Now43.88%Citigroup
David Hoang
 → $125Initiates → BuyGet Alert
12/12/2023Buy Now107.19%HC Wainwright & Co.
Raghuram Selvaraju
 → $180ReiteratesBuy → BuyGet Alert
11/07/2023Buy Now24.32%Cantor Fitzgerald
Charles Duncan
 → $108ReiteratesOverweight → OverweightGet Alert
09/25/2023Buy Now15.11%Mizuho
Graig Suvannavejh
 → $100ReiteratesBuy → BuyGet Alert
08/28/2023Buy Now15.11%Mizuho
Graig Suvannavejh
 → $100ReiteratesBuy → BuyGet Alert
08/22/2023Buy Now24.32%Cantor Fitzgerald
Charles Duncan
 → $108ReiteratesOverweight → OverweightGet Alert
08/11/2023Buy Now15.11%Mizuho
Graig Suvannavejh
$95 → $100MaintainsBuyGet Alert
08/08/2023Buy Now-6.76%B of A Securities
Jason Gerberry
$59 → $81UpgradeUnderperform → NeutralGet Alert
08/08/2023Buy Now107.19%HC Wainwright & Co.
Raghuram Selvaraju
$190 → $180MaintainsBuyGet Alert
08/08/2023Buy Now3.6%Piper Sandler
David Amsellem
$70 → $90UpgradeNeutral → OverweightGet Alert
07/17/2023Buy Now118.71%HC Wainwright & Co.
Raghuram Selvaraju
$200 → $190MaintainsBuyGet Alert
06/22/2023Buy Now19.71%Cantor Fitzgerald
Charles Duncan
 → $104ReiteratesOverweight → OverweightGet Alert
06/15/2023Buy Now26.62%Guggenheim
Yatin Suneja
 → $110ReiteratesBuy → BuyGet Alert
06/14/2023Buy Now9.35%Mizuho
Graig Suvannavejh
 → $95ReiteratesBuy → BuyGet Alert
06/12/2023Buy Now9.35%Mizuho
Graig Suvannavejh
 → $95ReiteratesBuy → BuyGet Alert
06/12/2023Buy Now3.6%Morgan Stanley
Vikram Purohit
$87 → $90MaintainsEqual-WeightGet Alert
05/11/2023Buy Now130.22%HC Wainwright & Co.
Raghuram Selvaraju
 → $200ReiteratesBuy → BuyGet Alert
05/11/2023Buy Now9.35%Mizuho
Graig Suvannavejh
$84 → $95MaintainsBuyGet Alert
05/09/2023Buy Now15.11%Guggenheim
Yatin Suneja
$90 → $100MaintainsBuyGet Alert
05/09/2023Buy Now19.71%Cantor Fitzgerald
Charles Duncan
 → $104Reiterates → OverweightGet Alert
05/09/2023Buy Now0.14%Morgan Stanley
Vikram Purohit
$83 → $87MaintainsEqual-WeightGet Alert
04/17/2023Buy Now130.22%HC Wainwright & Co.
Raghuram Selvaraju
 → $200Reiterates → BuyGet Alert
04/12/2023Buy Now-4.46%Morgan Stanley
Vikram Purohit
$85 → $83MaintainsEqual-WeightGet Alert
03/20/2023Buy Now130.22%HC Wainwright & Co.
Raghuram Selvaraju
$210 → $200MaintainsBuyGet Alert
03/13/2023Buy Now-3.31%Mizuho
Graig Suvannavejh
 → $84Reiterates → BuyGet Alert
03/06/2023Buy Now141.73%HC Wainwright & Co.
Raghuram Selvaraju
 → $210Reiterates → BuyGet Alert
03/01/2023Buy Now-3.31%Mizuho
Graig Suvannavejh
$86 → $84MaintainsBuyGet Alert
02/28/2023Buy Now3.6%Guggenheim
Yatin Suneja
$105 → $90MaintainsBuyGet Alert
02/28/2023Buy Now-2.16%Morgan Stanley
Vikram Purohit
$86 → $85MaintainsEqual-WeightGet Alert
02/14/2023Buy Now-40.14%B of A Securities
Jason Gerberry
 → $52Reiterates → UnderperformGet Alert
02/14/2023Buy Now141.73%HC Wainwright & Co.
Raghuram Selvaraju
 → $210Reiterates → BuyGet Alert
01/30/2023Buy Now-1.01%Mizuho
Graig Suvannavejh
$80 → $86MaintainsBuyGet Alert
01/05/2023Buy Now-13.67%Piper Sandler
David Amsellem
 → $75Initiates → NeutralGet Alert
12/23/2022Buy Now12.81%BTIG
Robert Hazlett
$62 → $98MaintainsBuyGet Alert
11/29/2022Buy Now-1.01%Morgan Stanley
Vikram Purohit
$73 → $86MaintainsEqual-WeightGet Alert
11/29/2022Buy Now-2.16%SVB Leerink
Marc Goodman
$65 → $85MaintainsOutperformGet Alert
11/11/2022Buy Now-7.91%Guggenheim
Yatin Suneja
$72 → $80MaintainsBuyGet Alert
11/09/2022Buy Now-7.91%Mizuho
Graig Suvannavejh
$76 → $80MaintainsBuyGet Alert
11/08/2022Buy Now-15.97%Morgan Stanley
Vikram Purohit
$74 → $73MaintainsEqual-WeightGet Alert
11/01/2022Buy Now9.35%Loop Capital
Esther Hong
 → $95Initiates → BuyGet Alert
10/14/2022Buy Now-17.12%Guggenheim
Yatin Suneja
$64 → $72MaintainsBuyGet Alert
10/14/2022Buy Now-14.82%Morgan Stanley
Vikram Purohit
$71 → $74MaintainsEqual-WeightGet Alert
09/30/2022Buy Now3.6%Jefferies
Chris Howerton
$92 → $90MaintainsBuyGet Alert
09/30/2022Buy Now-18.27%Morgan Stanley
Vikram Purohit
$75 → $71MaintainsEqual-WeightGet Alert
09/07/2022Buy Now-12.52%Mizuho
Graig Suvannavejh
 → $76Assumes → BuyGet Alert
08/30/2022Buy Now-13.67%Morgan Stanley
Vikram Purohit
$55 → $75MaintainsEqual-WeightGet Alert
08/23/2022Buy Now141.73%HC Wainwright & Co.
Raghuram Selvaraju
$180 → $210MaintainsBuyGet Alert
08/22/2022Buy Now-13.67%SVB Leerink
Marc Goodman
$50 → $75MaintainsOutperformGet Alert
08/10/2022Buy Now-36.69%Morgan Stanley
Vikram Purohit
$54 → $55MaintainsEqual-WeightGet Alert
07/08/2022Buy Now-37.84%Morgan Stanley
Vikram Purohit
$27 → $54MaintainsEqual-WeightGet Alert
06/29/2022Buy Now49.64%Cowen & Co.
Joseph Thome
$120 → $130MaintainsOutperformGet Alert
06/29/2022Buy Now-26.33%Cantor Fitzgerald
Charles Duncan
$47 → $64MaintainsOverweightGet Alert
05/03/2022Buy Now-43.6%Mizuho
Vamil Divan
$51 → $49MaintainsBuyGet Alert
04/27/2022Buy Now-68.92%Morgan Stanley
Vikram Purohit
$34 → $27MaintainsEqual-WeightGet Alert
03/29/2022Buy Now-11.37%Jefferies
Chris Howerton
$71 → $77MaintainsBuyGet Alert
03/02/2022Buy Now-42.45%SVB Leerink
Marc Goodman
$65 → $50MaintainsOutperformGet Alert
11/09/2021Buy Now-25.18%SVB Leerink
Marc Goodman
—MaintainsOutperformGet Alert
08/30/2021Buy Now107.19%HC Wainwright & Co.
Raghuram Selvaraju
—MaintainsBuyGet Alert
08/10/2021Buy Now-13.67%SVB Leerink
Marc Goodman
—MaintainsOutperformGet Alert
08/10/2021Buy Now84.17%Truist Securities
Joon Lee
—MaintainsBuyGet Alert
08/10/2021Buy Now-36.69%Mizuho
Vamil Divan
—MaintainsBuyGet Alert
08/10/2021Buy Now-60.86%Morgan Stanley
Vikram Purohit
—DowngradeOverweight → Equal-WeightGet Alert

FAQ

Q

What is the target price for Axsome Therapeutics (AXSM) stock?

A

The latest price target for Axsome Therapeutics (NASDAQ:AXSM) was reported by RBC Capital on July 22, 2024. The analyst firm set a price target for $131.00 expecting AXSM to rise to within 12 months (a possible 50.79% upside). 43 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Axsome Therapeutics (AXSM)?

A

The latest analyst rating for Axsome Therapeutics (NASDAQ:AXSM) was provided by RBC Capital, and Axsome Therapeutics reiterated their outperform rating.

Q

When was the last upgrade for Axsome Therapeutics (AXSM)?

A

The last upgrade for Axsome Therapeutics Inc happened on April 29, 2024 when Morgan Stanley raised their price target to $115. Morgan Stanley previously had an equal-weight for Axsome Therapeutics Inc.

Q

When was the last downgrade for Axsome Therapeutics (AXSM)?

A

The last downgrade for Axsome Therapeutics Inc happened on August 10, 2021 when Morgan Stanley changed their price target from $105 to $34 for Axsome Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Axsome Therapeutics (AXSM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axsome Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axsome Therapeutics was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.

Q

Is the Analyst Rating Axsome Therapeutics (AXSM) correct?

A

While ratings are subjective and will change, the latest Axsome Therapeutics (AXSM) rating was a reiterated with a price target of $131.00 to $131.00. The current price Axsome Therapeutics (AXSM) is trading at is $86.88, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch